New eczema pill shows promise in Mid-Stage trial
NCT ID NCT07441395
First seen Mar 10, 2026 · Last updated May 09, 2026 · Updated 10 times
Summary
This study tests a new daily pill called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). Researchers want to see if it reduces skin redness, itching, and rash better than a placebo. About 200 participants will take the pill or a dummy pill for 12 weeks, with regular check-ups to track safety and skin improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corvus Clinical Trials
RECRUITINGSouth San Francisco, California, 94080, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.